Clinical Trial Update: Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating remission of Type 2 diabetes with metabolic intervention using IDegLira; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• IDegLira (insulin degludec/liraglutide)

Snippet

Sponsor: Population Health Research Institute | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED